Title: A peroxisome proliferator-activated receptor ligand MCC-555 imparts anti-proliferative response in pancreatic cancer cells by PPARgamma-independent up-regulation of KLF4.
Journal: Toxicology and applied pharmacology20120901
Title: Stable reporter cell lines for peroxisome proliferator-activated receptor γ (PPARγ)-mediated modulation of gene expression.
Journal: Analytical biochemistry20110701
Title: MCC-555-induced NAG-1 expression is mediated in part by KLF4.
Journal: European journal of pharmacology20100710
Title: High-throughput quantification of a novel thiazolidinedione MCC-555 in rat plasma by ultra-fast liquid chromatography and its application in pharmacokinetic studies.
Journal: Talanta20090430
Title: Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.
Journal: Molecular cancer therapeutics20080901
Title: PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo.
Journal: American journal of physiology. Endocrinology and metabolism20071201
Title: Investigation of the lipophilic behaviour of some thiazolidinediones. Relationships with PPAR-gamma activity.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20071001
Title: Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner.
Journal: International journal of oncology20070501
Title: Quantitative determination of MCC-555, a novel insulin sensitizer in beagle dog plasma by high-performance liquid chromatography with fluorescence detection.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20060501
Title: A novel peroxisome proliferator-activated receptor gamma ligand, MCC-555, induces apoptosis via posttranscriptional regulation of NAG-1 in colorectal cancer cells.
Journal: Molecular cancer therapeutics20060501
Title: Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat.
Journal: Bone20060101
Title: Activation of PPARgamma is not involved in butyrate-induced epithelial cell differentiation.
Journal: Experimental cell research20051015
Title: A novel thiazolidinedione MCC-555 down-regulates tumor necrosis factor-alpha-induced expression of vascular cell adhesion molecule-1 in vascular endothelial cells.
Journal: Atherosclerosis20050901
Title: RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research20040215
Title: Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat.
Journal: International journal of experimental pathology20030401
Title: [KRP-297, MCC-555].
Journal: Nihon rinsho. Japanese journal of clinical medicine20011101
Title: A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties.
Journal: The Journal of biological chemistry19981204
